openPR Logo
Press release

Recent Research: Toxoplasmosis Testing Market Analysis to 2021

11-16-2017 11:58 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Recent Research: Toxoplasmosis Testing Market Analysis to 2021

The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and intestines of infected persons.

In addition, it is transmitted by pregnant women to their developing fetuses through the placenta. The severity of toxoplasmosis depends upon the stage of pregnancy at which women acquires the infection. Infection results in premature birth or spontaneous abortion. Toxoplasmosis exhibits mild symptoms such as swollen lymph nodes and discomfort. However, in individuals with HIV/AIDS, it results in severe, life threatening, and recurring symptoms.

Request for TOC @ https://www.persistencemarketresearch.com/toc/4289

Toxoplasmosis can be serious or fatal in fetuses, newborns, and people with weakened immune systems. Serology, polymerase chain reaction, and immunoperoxidase stain are some of the tests used to diagnose toxoplasmosis. Serology is used to measure immunoglobulin G (IgG) in infected persons. Toxoplasmosis testing is a blood test used to check for the availability of antibodies for T. gondii. Hospitals, commercial or private laboratories, and physician offices are among the common users of toxoplasmosis testing.

Currently, North America dominates the global toxoplasmosis testing market, followed by Europe. This is due to the rising prevalence of infectious diseases and increasing demand for effective testing methods by diagnostics laboratories in these regions. However, Asia is expected to be the fastest growing market in the next five years, due to the region’s developing healthcare infrastructure and increasing government initiatives for better healthcare facilities. Moreover, a large patient population base is also driving the growth of the toxoplasmosis testing market in this region.

Rising technological advancements in infection control instruments, an increasing number of anti-infective drugs, and the development of food sterilization and disinfection methods are among the key factors driving the growth of the global toxoplasmosis testing market. In addition, a rising birth rate and improving healthcare infrastructure in developing countries such as India, China and Brazil are also fuelling the growth of the global toxoplasmosis testing market. However, the lack of awareness among people about parasitic infections and economic downturn and saturation, and the high cost of toxoplasmosis tests are restraining the growth of the global toxoplasmosis testing market. In addition, stringent and time-consuming regulatory policies also impede the market’s growth.

Employment of single-use technology products and the availability of low-cost tests for toxoplasmosis could open up opportunities for new players in the global toxoplasmosis testing market. In addition, increasing focus on emerging markets such as India and China could also open up an opportunity for the market players in the global Toxoplasmosis testing market. Moreover, safety and quality of toxoplasmosis testing could be a challenge for the growth of the global toxoplasmosis testing market.

Make an Enquiry @ https://www.persistencemarketresearch.com/samples/4289

A growing number of mergers and acquisitions is a recent trend in the global toxoplasmosis testing market. The major companies operating in this market are Abbott Laboratories, Affymetrix, Inc., Bio-Rad Laboratories, Inc., and Beckman Coulter, Inc. Other significant players are Biomerica, Inc., Cepheid, Inc., Biotest, and GenBio.

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway,7th Floor
New York City, NY 10007
United States
T: +1-646-568-7751
Tollfree: +1 800-961-0353
Email: sales@persistencemarketresearch.com
Web: www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Recent Research: Toxoplasmosis Testing Market Analysis to 2021 here

News-ID: 819965 • Views: 261

More Releases from Persistence Market Research

Revolutionizing Sleep Apnea Treatment: Exploring the Continuous Positive Airway …
Market Overview: The continuous positive airway pressure (CPAP) devices market refers to the production, distribution, and utilization of devices designed to deliver a continuous flow of pressurized air to individuals with sleep apnea and other respiratory conditions. CPAP devices are commonly used to treat obstructive sleep apnea (OSA), a disorder characterized by the repetitive collapse of the upper airway during sleep. These devices help maintain open airways, preventing breathing interruptions
Revolutionizing Food Packaging: Foodservice Packaging Market Shows Rapid Expansi …
Persistence Market Research estimates that in 2022, the foodservice packaging market would bring in US$461 billion. The leading market players will hold a sizable proportion of the foodservice packaging market in 2022 as the demand for foodservice packaging will increase. By 2033, the global market for foodservice packaging is anticipated to reach US$ 824.5 billion, expanding at a 5.7% CAGR. Today, we are thrilled to announce groundbreaking advancements in the foodservice
Smart Pillows Market Gains Momentum as Technology Integration Enhances Sleep Qua …
Persistence Market Research estimates that in 2022, the smart pillows market would bring in US$654.7 million. The leading market players will occupy a significant proportion of the market for smart pillows in 2022 as the demand for them increases. By 2033, the global market for smart pillows is anticipated to reach US$ 8.05 billion, expanding at a CAGR of 21.3% between 2023 and 2033. The smart pillows market is witnessing a
Dishwashing Liquids Market Expands as Consumers Embrace Convenient and Effective …
The dishwashing liquid market will grow from its current market size of US$ 11.84 Billion to US$ 23.73 Billion by the end of 2032, at a 7.2% CAGR. Currently, the global market for dishwashing goods is made up of 14%-17% of sales of dishwashing solutions. The dishwashing liquids market is witnessing a significant surge in demand as consumers seek effective and convenient solutions for maintaining clean and sanitary kitchens. Dishwashing liquids

All 5 Releases


More Releases for Toxoplasmosis

Technological Apogee To Catalyze The Toxoplasmosis Testing Market
Toxoplasmosis is an infection induced by Toxoplasma gondii parasite. Mostly cats serve as reservoir for this parasite. Based on the 2017 disease data from European Centre for Disease Prevention and Control, countries including Poland, United Kingdom and Germany had comparatively higher number of reported cases of congenital toxoplasmosis in infants creating a need for preventive measures to be taken for toxoplasmosis testing. This disease is transmitted through improper cooked meat consumption,
Toxoplasmosis Pipeline Review H1 2017
Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Toxoplasmosis - Pipeline Review, H1 2017, provides an overview of the Toxoplasmosis (Infectious Disease) pipeline landscape. Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. Get Sample Copy http://www.reportsweb.com/inquiry&RW0001858649/sample Report Highlights Publisher's Pharmaceutical and
Toxoplasmosis Testing Market Valuation By 2021
The term toxoplasmosis refers to the infectious disease caused by the parasite Toxoplasma gondii. It may cause acute or chronic infection. Toxoplasmosis is caused by the consumption of improperly cooked mutton, pork, goat, or beef. It is also caused due to the transmission of T. gondii parasite through open wounds, contaminated raw meat, and food or dust contaminated with cat feces. These parasites are found in the kidney, bladder, and
Toxoplasmosis Industry Assessment And Therapeutics Analysis Forecasts To 2017
Overview Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740059-toxoplasmosis-pipeline-review-h2-2017 Report Highlights The Pharmaceutical and Healthcare latest pipeline guide Toxoplasmosis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Toxoplasmosis (Infectious
Market Overview of Toxoplasmosis Research and Detailed Forecast 2018
Summary Toxoplasmosis is a disease that results from infection with the Toxoplasma gondii parasite. Symptoms include body aches, swollen lymph nodes, headache, fever and fatigue. Risk factors include HIV/AIDS, chemotherapy and immunosuppressant drugs. Treatment includes an antimalarial drug and antibiotics. GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2740059-toxoplasmosis-pipeline-review-h2-2017 Report Highlights Pharmaceutical and Healthcare latest pipeline guide Toxoplasmosis - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Toxoplasmosis (Infectious Disease), complete
Toxoplasmosis Diagnostic Testing Market: Evolving market trends and dynamics
Toxoplasmosis is an infectious disease caused by protozoan parasite Toxoplasma gondii, one of the world’s most dreaded parasite. There are 3 major genotypes of Toxoplasma gondii, namely (type 1, type 2, and type 3). These genotypes differ in their pathogenicity and prevalence among people around the world. Toxoplasmosis may be caused by transmission of T.gondii parasite through open wounds, consumption of contaminated raw meat, mutton, pork, beef, or by transfusion